Nascent Pharma Holdings, Inc. (NASC)
Oxford Ledge is still expanding full research coverage of NASC. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company develops and sells hemp-derived cannabinoid products and durable medical devices while pursuing commercialization of cannabis patents through its Nascent subsidiary.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2024-11-19
- SC 13G/A Amended passive ownership disclosure 2024-11-14
- 8-K Entry into material agreement; Delisting / transfer of listing; 3.03; Departure/election of directors or officers; Amendments to articles or bylaws; Financial statements and exhibits 2024-10-28
- 10-Q Quarterly financial report (unaudited) 2024-08-19
- 10-Q/A Amended quarterly report 2024-07-17
Source: SEC EDGAR.
Insider activity
3 recent insider (SEC Form 4) filings on record for NASC. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open NASC in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.